Related references
Note: Only part of the references are listed.Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis
Lina Marenco-Hillembrand et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
The path forward for anti-programmed cell death-1 therapy in gliomas
Nazanin Majd et al.
CURRENT OPINION IN NEUROLOGY (2019)
Chemotherapy Treatment and Trials in Low-Grade Gliomas
Laura E. Donovan et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2019)
Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas
Anja Smits et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2019)
Risk Factors for Malignant Transformation of Low-Grade Glioma
Erin S. Murphy et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial
Carmen Balana et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Association of the Extent of Resection With Survival in Glioblastoma A Systematic Review and Meta-analysis
Timothy J. Brown et al.
JAMA ONCOLOGY (2016)
Upfront chemotherapy and subsequent resection for molecularly defined gliomas
Hikaru Sasaki et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Neoadjuvant chemotherapy for brain tumors in infants and young children
Junya Iwama et al.
Journal of Neurosurgery-Pediatrics (2015)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2015)
Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma
Katherine B. Peters et al.
ONCOLOGIST (2015)
Bevacizumab in Combination With Radiotherapy and Temozolomide for PatientsWith Newly Diagnosed Glioblastoma Multiforme
Myra E. van Linde et al.
ONCOLOGIST (2015)
Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study
Kenneth F. Hofland et al.
ACTA ONCOLOGICA (2014)
Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade glioma
Jasmin Jo et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients
Marie Blonski et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life
Marie Blonski et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Does Extent of Resection of a Glioblastoma Matter?
Michael A. Vogelbaum
NEUROSURGERY (2012)
Guidelines on management of low-grade gliomas: report of an EFNS-EANO* Task Force
R. Soffietti et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma
Wenting Wu et al.
NEURO-ONCOLOGY (2010)
Preoperative Chemotherapy for Infiltrative Low-Grade Oligoastrocytoma: a Useful Strategy to Maximize Surgical Resection - Case Report
Giannantonio Spena et al.
NEUROLOGIA MEDICO-CHIRURGICA (2010)
Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival?
Faramarz-Allandini et al.
WORLD NEUROSURGERY (2010)
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
et al.
NEUROSURGERY (2009)
Radical surgery after chemotherapy: a new therapeutic strategy to envision in grade II glioma
Hugues Duffau et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Neoadjuvant temozolomide followed by complete resection of a 1p-and 19q-deleted anaplastic oligoastrocytoma: Case study
AD Voloschin et al.
NEURO-ONCOLOGY (2005)
Complete surgical resection in children with low-grade astrocytomas after neoadjuvant chemotherapy
ET Valera et al.
CHILDS NERVOUS SYSTEM (2003)
Share Paper
